Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety, pharmcokinetic and pharmacodynamic study of DS-2969b in healthy subjects: A phase I single-ascending dose study

Trial Profile

Safety, pharmcokinetic and pharmacodynamic study of DS-2969b in healthy subjects: A phase I single-ascending dose study

Completed
Phase of Trial: Phase I

Latest Information Update: 21 May 2018

At a glance

  • Drugs DS 2969 (Primary)
  • Indications Clostridium difficile infections
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 21 May 2018 New trial record
    • 10 May 2018 Results published in the Journal of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top